Posted On: 11/17/2014 3:11:43 AM
Post# of 250675
Dongsheng Pharmaceutical International Co. Ltd. (DNGH) Financials Oct 10, 2014, 7:10 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Dongsheng Pharmaceutical International Co. Ltd.
Fiscal year is July-June. All values USD millions. 2009 2010 5-year trend
Sales/Revenue - - - 17.13M 20.48M
Cost of Goods Sold (COGS) incl. D&A - - - 12.28M 15.17M
COGS excluding D&A - - - 12.27M 15.16M
Depreciation & Amortization Expense - - - 8,484 13,212
Depreciation - - - 8,484 13,212
Amortization of Intangibles - - - 0 0
Gross Income - - - 4.85M 5.31M
2009 2010 5-year trend
SG&A Expense - - - 1.65M 1.24M
Research & Development - - - 0 0
Other SG&A - - - 1.65M 1.24M
Other Operating Expense - - - 0 0
Unusual Expense - - - 0 0
EBIT after Unusual Expense - - - 0 0
Non Operating Income/Expense - - - (8,329) 1.35M
Non-Operating Interest Income - - - - -
Equity in Affiliates (Pretax) - - - 0 0
Interest Expense - - - 1,480 4,540
Gross Interest Expense - - - 1,480 4,540
Interest Capitalized - - - 0 0
Pretax Income - - - 3.19M 5.41M
Income Tax - - - 800,084 1.35M
Income Tax - Current Domestic - - - 378,748 994,450
Income Tax - Current Foreign - - - 0 0
Income Tax - Deferred Domestic - - - 421,336 360,472
Income Tax - Deferred Foreign - - - 0 0
Income Tax Credits - - - 0 0
Equity in Affiliates - - - 0 0
Other After Tax Income (Expense) - - - 0 0
Consolidated Net Income - - - 2.39M 4.06M
Minority Interest Expense - - - 0 0
Net Income - - - 2.39M 4.06M
Extraordinaries & Discontinued Operations - - - 0 0
Extra Items & Gain/Loss Sale Of Assets - - - 0 0
Cumulative Effect - Accounting Chg - - - 0 0
Discontinued Operations - - - 0 0
Net Income After Extraordinaries - - - 2.39M 4.06M
Preferred Dividends - - - 0 0
Net Income Available to Common - - - 2.39M 4.06M
EPS (Basic) - - - 0.15 0.25
Basic Shares Outstanding - - - 15.83M 16.14M
EPS (Diluted) - - - 0.15 0.25
Diluted Shares Outstanding - - - 15.83M 16.14M
EBITDA - - - 3.21M 4.08M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Dongsheng Pharmaceutical International Co. Ltd.
Fiscal year is July-June. All values USD millions. 2009 2010 5-year trend
Sales/Revenue - - - 17.13M 20.48M
Cost of Goods Sold (COGS) incl. D&A - - - 12.28M 15.17M
COGS excluding D&A - - - 12.27M 15.16M
Depreciation & Amortization Expense - - - 8,484 13,212
Depreciation - - - 8,484 13,212
Amortization of Intangibles - - - 0 0
Gross Income - - - 4.85M 5.31M
2009 2010 5-year trend
SG&A Expense - - - 1.65M 1.24M
Research & Development - - - 0 0
Other SG&A - - - 1.65M 1.24M
Other Operating Expense - - - 0 0
Unusual Expense - - - 0 0
EBIT after Unusual Expense - - - 0 0
Non Operating Income/Expense - - - (8,329) 1.35M
Non-Operating Interest Income - - - - -
Equity in Affiliates (Pretax) - - - 0 0
Interest Expense - - - 1,480 4,540
Gross Interest Expense - - - 1,480 4,540
Interest Capitalized - - - 0 0
Pretax Income - - - 3.19M 5.41M
Income Tax - - - 800,084 1.35M
Income Tax - Current Domestic - - - 378,748 994,450
Income Tax - Current Foreign - - - 0 0
Income Tax - Deferred Domestic - - - 421,336 360,472
Income Tax - Deferred Foreign - - - 0 0
Income Tax Credits - - - 0 0
Equity in Affiliates - - - 0 0
Other After Tax Income (Expense) - - - 0 0
Consolidated Net Income - - - 2.39M 4.06M
Minority Interest Expense - - - 0 0
Net Income - - - 2.39M 4.06M
Extraordinaries & Discontinued Operations - - - 0 0
Extra Items & Gain/Loss Sale Of Assets - - - 0 0
Cumulative Effect - Accounting Chg - - - 0 0
Discontinued Operations - - - 0 0
Net Income After Extraordinaries - - - 2.39M 4.06M
Preferred Dividends - - - 0 0
Net Income Available to Common - - - 2.39M 4.06M
EPS (Basic) - - - 0.15 0.25
Basic Shares Outstanding - - - 15.83M 16.14M
EPS (Diluted) - - - 0.15 0.25
Diluted Shares Outstanding - - - 15.83M 16.14M
EBITDA - - - 3.21M 4.08M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
(0)
(0)
